UH2 Project: Blood Pressure Medication Timing Study (BPMedTime)

UH2 Project: Blood Pressure Medication Timing Study (BPMedTime)

Principal Investigator: Gary Rosenthal, MD

Sponsoring Institution: University of Iowa

Collaborator: Duke University Health System

NIH Institute Providing Oversight: The National Center for Complementary and Integrative Health (NCCIH)

Program Official: Wendy Weber (NCCIH)

Project Scientist: Catherine Meyers (NCCIH)

NIH Project Number: 1UH2AT007784

Blood pressure exhibits circadian variability, decreasing during sleep (“nighttime dipping”) and increasing quickly upon arising. In the last 20 years, the development and increasing use of longer acting antihypertensive medications has led to improved patient compliance. However, many once-daily antihypertensives require 60 to 90 minutes to achieve peak plasma concentrations after ingestion and do not maintain sustained plasma concentrations for a full 24 hours. Thus, when taken in the morning, medication concentrations may not be high enough to fully protect against the morning surge in blood pressure that occurs in most patients.

The goal of the BPMedTime randomized pragmatic trial is to evaluate the risk of adverse cardiovascular events in patients who are instructed to take their currently prescribed once-daily antihypertensive medications at bedtime compared with patients who continue to take their once-daily antihypertensive medications in the morning or afternoon. The rationale for the trial is that nighttime dosing may better control the early morning rise in blood pressure that occurs in most patients and that is associated with an increased risk of acute cardiovascular events. Nighttime dosing may also promote greater nighttime dipping of blood pressure in patients with hypertension and other chronic illnesses, such as chronic kidney disease and diabetes. Such nighttime dipping has been shown to be protective of cardiovascular events.

Project  Presentation

Supplementary Material

Regulatory and Ethics Support Documentation


Efficacy and safety of nighttime dosing of antihypertensives: review of the literature and design of a pragmatic clinical trial. J Clin Hypertens (Greenwich). 2014;16(2):115-121.


8/2/2013: PCT Grand Rounds: "Blood Pressure Medication Timing Study (BPMedTime)" (video; slides)

4/5/2013: PCT Grand Rounds: "Nighttime Dosing of Anti-Hypertensive Medications" (video; slides)

Back to top


UH2 Project: Blood Pressure Medication Timing Study (BPMedTime): UH2 Project: Blood Pressure Medication Timing Study (BPMedTime). In: Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. Bethesda, MD: NIH Health Care Systems Research Collaboratory. Available at: https://rethinkingclinicaltrials.org/uh2-project-blood-pressure-medication-timing-study-bpmedtime/. Updated January 14, 2020.